Next Article in Journal
How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?
Next Article in Special Issue
A Mini-Review of Anti-Listerial Compounds from Marine Actinobacteria (1990–2023)
Previous Article in Journal
A Multifaceted Intervention and Its Effects on Antibiotic Usage in Norwegian Nursing Homes
Previous Article in Special Issue
Exploring the Multifaceted Potential of a Peptide Fraction Derived from Saccharomyces cerevisiae Metabolism: Antimicrobial, Antioxidant, Antidiabetic, and Anti-Inflammatory Properties
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Untargeted MS-Based Metabolomic Analysis of Termite Gut-Associated Streptomycetes with Antifungal Activity against Pyrrhoderma noxium

1
School of Science, Technology and Engineering, University of the Sunshine Coast, Maroochydore BC, QLD 4558, Australia
2
Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore BC, QLD 4558, Australia
3
Brisbane City Council, Program, Planning and Integration, Brisbane Square, Level 10, 266 George Street, Brisbane, QLD 4000, Australia
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(9), 1373; https://doi.org/10.3390/antibiotics12091373
Submission received: 5 August 2023 / Revised: 21 August 2023 / Accepted: 22 August 2023 / Published: 28 August 2023
(This article belongs to the Special Issue Microbial Natural Products as a Source of Novel Antimicrobials)

Abstract

:
Pyrrhoderma noxium is a plant fungal pathogen that induces the disease of brown root rot in a large variety of tree species. It is currently infecting many of the amenity trees within Brisbane City of Queensland, Australia. Steering away from harmful chemical fungicides, biological control agents offer environmentally friendly alternatives. Streptomycetes are known for their production of novel bioactive secondary metabolites with biocontrol potential, particularly, streptomycete symbionts isolated from unique ecological niches. In this study, 37 termite gut-associated actinomycete isolates were identified using molecular methods and screened against P. noxium. A majority of the isolates belonged to the genus Streptomyces, and 15 isolates exhibited strong antifungal activity with up to 98.5% mycelial inhibition of the fungal pathogen. MS/MS molecular networking analysis of the isolates’ fermentation extracts revealed several chemical classes with polyketides being among the most abundant. Most of the metabolites, however, did not have matches to the GNPS database, indicating potential novel antifungal compounds in the active extracts obtained from the isolates. Pathway enrichment and overrepresentation analyses revealed pathways relating to polyketide antibiotic production, among other antibiotic pathways, further confirming the biosynthetic potential of the termite gut-associated streptomycetes with biocontrol potential against P. noxium.

Graphical Abstract

1. Introduction

Invasive fungal pathogens pose an increasing threat to agriculture and food industries worldwide [1,2]. Pyrrhoderma noxium (P. noxium), formally known as Phellinus noxius [3], is a phytopathogenic fungus belonging to the family Hymenochaetaceae and the division Basidiomycota. It induces the disease of brown root rot, although it is classed as a white-rot fungus due to its ability to degrade lignin along with cellulose and hemicellulose [3]. This pathogen has caused much destruction throughout tropical and subtropical regions and is widespread throughout Taiwan [4,5,6], Japan [7,8], China [9,10], and Australia [11,12,13,14]. It is able to infect over 250 tree species, including herbaceous, broad-leaved, fruit, ornamental, and coniferous woody trees [15,16] within forests, landscapes, and orchards [17]. Infection begins within the roots and eventually extends to the basal stem [17]. Early stages of the disease are largely asymptomatic; therefore, diagnosis and treatment are usually hindered, and the tree health is too far declined for intervention [18]. Symptoms can include chlorosis, dieback, defoliation, and decay of stem and roots [19,20].
In response to the pressing need for sustainable and eco-friendly solutions to combat invasive fungal pathogens and reduce reliance on chemical fungicides, biological control methods have gained significant interest [21]. These methods involve the use of natural antagonists, such as functional microorganisms, to minimise the harmful effects of chemical agents used in conventional agriculture [22,23]. Among the diverse sources of natural antagonists, actinomycetes have emerged as prominent candidates as they are one of the largest producers of bioactive secondary metabolites and new antibiotics, with a recent focal shift on rare actinomycetes as an increasing target source for new secondary metabolites [24,25]. In fact, rare members of the genus Streptomyces persist to be the largest producer of new innovative metabolites [26]. Between 2015 and 2020, a significantly large number of novel Streptomyces spp. were isolated from various niches, such as extreme environments, sediments, marine environments, and symbionts [22,24]. Streptomycetes as microbial symbionts are distributed in a wide range of environments, including insect guts, cuticles, and nests [27]. Within this mutualistic relationship, streptomycetes assist insects in the breaking down of food, provide a synthesis of essential metabolites, alter gene descriptions, and combat pathogens and competitors [28]. One such source of these specialised streptomycetes symbionts is the guts of termites. Termites belong to the order Isoptera and have three main components of their alimentary tract: the foregut (stomodeum), the midgut (mesenteron), and the hindgut (proctodeum) [29]. They predominately feed on litter tissue and wood, or in other words, difficult-to-digest lignocelluloses; therefore, they depend on beneficial symbioses with a diversity of microflora for digestion and acquisition of supplementary nutrition [28]. Previous studies have revealed that actinomycetes are among the most dominant bacteria identified within the termite’s symbiotic lifestyle [29]. It is therefore possible that these unexplored insect guts may house rare species of actinomycetes with the ability to produce novel NPs [28,30]. To unravel the intricacies of these NPs in understudied streptomycetes, a metabolomic approach has proved to be a powerful tool [31]. Moreover, molecular networking [32] allows for the dynamic organisation of experimental spectra into families/classes based on spectral similarity with established MS/MS databases. It also provides visualisation and annotation of non-targeted mass spectrometry data [33,34].
In this study, 37 termite gut-associated actinomycetes selected from the University of the Sunshine Coast’s Microbial Library [35,36,37] were screened for antifungal activity against phytopathogen P. noxium. Their metabolic profiles were investigated using quadrupole time-of-flight (QTOF) mass spectrometry (MS) as well as molecular networking techniques for the purposes of screening and predicting bioactive molecules from the termite gut-associated actinomycetes active extracts and prioritising the best candidate(s) as potential biological control agents against phytopathogen P. noxium.

2. Results and Discussion

2.1. Phylogeny of Termite Gut-Associated Actinomycetes Based on the 16S rRNA Oligonucleotide Analysis

From the 37-termite gut-associated actinomycetes obtained from the UniSC’s Microbial Library, 32 of them (86%) had almost complete 16S rRNA gene sequences aligned with corresponding sequences of representative type strains of the genus Streptomyces (Tables S1 and S2). Five of the isolates (13%) aligned with the genus Micromonospora and one strain aligned with the genus Saccharopolyspora (Tables S1 and S2). Phylogenetic analysis demonstrated putative sequence identity percentage between 97 and 100% (Figure S1). The dominance of Streptomyces isolates within the termite gut aligned with previous studies and demonstrated the crucial role these bacteria play in termite symbiosis [38,39]. One study analysed the phylogeny of 118 actinomycete isolates collected from three types of termite nests (mound, carton, and subterranean nests) and determined Streptomyces spp. to be the most dominant genus accounting for approximately 60% of the isolates [40]. Another study completed a 16S analysis of 16 actinomycetes isolates from termite guts and found 9 of them aligned with the genus Streptomyces [41].

2.2. Screening for Antifungal Activity from Termite Gut-Associated Actinomycete Isolates against P. noxium

All 37 actinomycete isolates underwent a preliminary evaluation for antifungal activity against P. noxium using the co-culture assay technique (Table S2). From this, 15 actinomycete isolates demonstrated strong antifungal activity against the fungal pathogen (Figure 1A). The mean inhibition percentages are demonstrated in Figure 1B. The results showed significant differences between the control and co-culture plates (F (14, 60) = 152.880) p ≤0.001) with isolate USC-595B presenting with the strongest antifungal activity with a mean value of 98.5% mycelial inhibition. This was followed by USC-6918 with 94.5% and USC-6919 with 92.0% inhibition, respectively. These active isolates might therefore be a valuable reservoir of bioactive compounds with antifungal properties. As per the phylogenetic analysis, the 15 isolates demonstrating the potent antifungal activity showed clustering within the genus Streptomyces.

2.3. Antifungal Activity from Streptomycetes Fermentation Extracts against P. noxium

The 15 selected antifungal Streptomyces isolates underwent fermentation and extraction of their natural products. The resulting fermentation extracts were further tested for persistent antifungal activity using the Kirby-Bauer disk-diffusion method (Figure 1C). USC-595B demonstrated persistent strong antifungal activity, and USC-6916 and USC-6928 also displayed a substantial increase in antifungal activity compared with the initial co-culture assays (Figure 2A). The antifungal activity of some of the Streptomyces isolates, including USC-6904, USC-6927, USC-6910, and USC-6909, was reduced. This decrease might be due to the absence of antifungal volatile compounds or compound degradation during solvent extraction and evaporation. Based on these disk-diffusion activity assays, isolates presenting with the strongest activities and, therefore, of interest include USC-595B, USC-6904, UCS-6914, USC-6916, USC-6918, USC-6919, USC-6927, and USC-6928. These isolates and their closest related species can be linked to previous studies demonstrating antifungal activities. For instance, USC-595B was found to be most similar to Streptomyces platensis, which was identified as a strong antifungal strain [42,43,44]. Resormycin is an herbicidal and antifungal antibiotic isolated from S. platensis, which demonstrated activity against numerous fungal phytopathogens [45]. Wan et al. (2008) also found S. platensis to be an effective biocontrol agent for the suppression of many plant-pathogenic fungi, including Botrytis cinerea, Rhizoctonia solani, and Sclerotinia sclerotiorum. Additionally, biosynthetic gene clusters of Phoslactomycins (PLMs), which are polyketide natural products and important antifungals, were identified from S. platensis [46]. USC-6904 and USC-6914 were most similar to S. catenulae, which demonstrated antifungal activity against the fungal pathogen P. citriasiana [47]. USC-6916 was most similar to S. gelaticus, which was assessed for antifungal activity against basal stem rot caused by Ganoderma boninense using co-culture assays and found to produce up to 100% inhibition. The subsequent crude extracts generated from this strain demonstrated activity of around 87.5% inhibition from a 10% concentration [48]. USC-6918 was most similar to S. luozhongensis, which was found to have antifungal activity against Saccharomyces cerevisiae, Aspergillus flavus, A. niger, Penicillium citrinum, and Candida albicans [49]. USC-6919 was most similar to the thermophilic S. thermocarboxydus, which was shown to be a promising biocontrol agent against strawberry anthracnose caused by Glomerella cingulate [50]. USC-6927 was most similar to S. alni and was found to have antifungal activity against the root rot of grapevine [50]. USC-6928 was most similar to S. diastaticus, which was found to produce the macrolide antibiotics oligomycin A and C, which exhibited strong activity against A. niger, Alternaria alternata, B. cinerea, and Phytophthora capsica [51]. This further exemplifies the biopotential of these isolates to produce antifungal secondary metabolites for the purposes of biocontrol.

2.4. Metabolite Diversity Analysis of Streptomycetes Fermentation Extracts Using Untargeted MS-Based Metabolomic Approach

Principal component analysis (PCA) of the MS data was generated by comparing the chemical diversity between the 15 streptomycete fermentation extracts (Figure 2A). The PCA demonstrated a clear clustering of samples, indicating spectral similarities between isolates USC-6904, USC-6914, USC-6918, USC-6919, USC-6927, and USC-6928. The remaining isolates had a clear distinction between this cluster but still displayed differences between each other. It can also be noted that USC-6923 displayed the largest metabolic diversity. Additionally, USC-595A and USC-6916 also displayed a degree of similarity in their metabolic profiles. The generated PCA in Figure 2B displays a comparison between the 8 identified active extracts and the remaining 7 non-active extracts. The non-active extracts show a larger chemical diversity; however, there is a great deal of overlap with the active extracts.

2.5. Molecular Networking and Identification of Bioactive Compounds within the Streptomycetes Fermentation Extracts

A molecular network (MN) was generated for the positive and negative electrospray ionisation mode datasets to detect as many compounds as possible. The MN of the positive dataset consisted of 6994 nodes, of which 114 were annotated by the GNPS spectral library database (Figure 3A). The negative dataset comprised 5629 nodes, and 38 nodes were annotated (Figure 3B). Each node represented a metabolite based on its molecular ion signal, and the edges connecting them represented the similarity of MS/MS fragmentation patterns among the nodes. To further enhance chemical structural information within the MN, the in silico structure annotation from the GNPS library search was incorporated into the network using the MolNetEnhancer workflow, which allowed for chemical class annotations using ClassyFire chemical ontology. It is apparent that the termite gut-associated streptomycetes produce structurally diverse compounds both between ionisation modes and between the individual samples (Figure 3). The identified chemical classes include organoheterocyclic compounds, lipids and lipid-like molecules, organic acids and derivatives, phenylpropanoids and polyketides, organic oxygen compounds, benzenoids, organic nitrogen compounds, nucleotides/sides, and lignans and neolignans (Figures S2 and S3). The most abundant chemical classes observed in node clusters include organic oxygen compounds, phenylpropanoids and polyketides, organic acids and derivatives, and lipids and lipid-like molecules. However, a majority of the metabolites visualised in the MN did not have a match to the chemical class annotations due to a lack of annotations from the GNPS library, indicating potential novel metabolites.
Streptomycetes are known to synthesise various antimicrobial compounds belonging to chemical classes such as aminoglycosides, peptides, ansamycins, β-lactams, tetracyclines, macrolides, lincosamides, epoxides, polyketides terpenoids, flavones, and aminocoumarins [52,53]. Many of these described chemical classes were also identified within the molecular network of the fermentation extracts of termite gut-associated Streptomyces isolates. Polyketides constitute a substantial and diverse group of secondary metabolites that display significant structural variability and versatile biological functions [54]. Beyond their pharmaceutical significance, actinomycete polyketides have also gained much interest in crop protection. Examples of these actinomycete polyketide pesticides include avermectins, milbemycins, and spinosyns, all of which offer a form of protection for plants against various pathogens and have been successfully commercialised and used in the agricultural field [55]. As seen in Figure 3, polyketide metabolites are among the most dominant observed in the metabolome of the termite gut-associated streptomycetes. Accordingly, they were selected for further investigation.

2.5.1. Isoflavonoids

Flavonoids and isoflavonoids are versatile natural products with extensive pharmacological activities. They have extremely low toxicity, making them compounds of interest and a “hotspot” for drug discovery and development [56]. However, research on flavonoids has favoured plant sources, resulting in relatively less focus on microorganisms as potential sources for novel flavonoids [56,57,58]. Within this class, a cluster of isoflavones, including daidzein (m/z 255.065 [M+H]+) and genistein (m/z 271.061 [M+H]+), were tentatively identified within the GNPS library (Figure 4). One study found that 10% of their 200 tested soil Streptomyces isolates produced daidzein and genistein and that genistein increased the production of polyketide antibiotics by 11–42% within its fermentation extracts [59]. The potential discovery of new isoflavonoids may be found in termite-associated streptomycetes as a study found three new isoflavonoid glycosides, which were isolated from termite-associated Streptomyces spp. recovered from the cuticle of South African termites, and as such were named termisoflavones A-C. These isolates were also found to produce daidzein and genistein [60]. Derivatives of daidzein and genistein, 7-O-β-D-glucosyl-genistein and 7-O-β-D-glucosyl-daidzein, have also demonstrated considerable antifungal activity against P. citricarpa, meaning there may be potential for antifungal activity against P. noxium [61]. These two compounds were produced in isolates USC-595C, USC-595A, USC-6928, and USC-6916.

2.5.2. Macrolides

Macrolides were originally isolated from Streptomyces species and are antibiotics consisting of a macrocyclic lactone ring, often 14-, 15- or 16-membered ring compounds with which various amino sugars are attached [62]. The most common macrolides are oleandomycin isolated from Streptomyces antibioticus, spiramycin isolated from S. ambofaciens, and erythromycin isolated from S. erythreus. Recent findings of new macrolide antibiotics from Streptomyces species have demonstrated potent antifungal activity. For instance, nine new polyene macrolides were isolates from deep-sea-derived Streptomyces antibioticus that demonstrated antifungal activity against Candida albicans [63]. Additional four new macrolides named venturicidins G-J were isolated from Streptomyces sp. SN5452, exhibiting strong inhibition towards Pyricularia oryzae, which causes the destructive rice blast disease [53]. A cluster of macrotetrolide antibiotics were also tentatively identified within this class, including nonactin (m/z 737.450 [M+H]+), monactin (m/z 768.495 [M+NH4]+), dinactin (m/z 765.481 [M+H]+), trinactin (m/z 779.494 [M+H]+), bonactin (m/z 418.203 [M+NH4]+), and tetranactin (m/z 793.512 [M+H]+), all found in isolates USC-595A and USC-595C (Figure 5). These macrolides are also known to be produced by a variety of Streptomyces spp., particularly by S. globisporus [64]. They exhibit antibacterial and antifungal activity as well as acaricidal, insecticidal, coccidiostatic, and anthelminthic activities [65]. One study investigated the bioactive compounds of S. araugoniae that proved effective against many phytopathogenic fungi and found a complex of macrotetrolides that included these compounds, all of which presented with antifungal activity against Botrytis cinerea [66]. Another study found that dinactin had broad inhibitory activity towards multiple phytopathogenic fungi, including Colletotrichum gloeosporioides [67]. A macrolide antibiotic within a separate cluster was identified as oligomycin A (m/z 791.531 [M+H]) and is reported to be produced by some strains of Streptomyces. They have a broad spectrum of activities against organisms such as fungi, bacteria, and nematodes. Oligomycin was first described as a new antifungal antibiotic in Streptomyces diasatochromogenes with nine isomers identified soon after [68]. A study conducted by Chakraborty (2020) investigated oligomycins produced by streptomycetes and evaluated the in vitro suppressive effects on hyphal growth, condidogenesis, conidial germination, and appressorial formation of the wheat blast fungus Magnaporthe oryzae and found strong inhibitory activity across all areas [69]. This oligomycin cluster was found in isolates USC-592, USC-595A, USC-6923, and USC-6928 (Figure 5). A separate phenylpropanoid and polyketide cluster identified as polycyclic tetramate macrolactum (PTM) clifednamide A (m/z 493.271 [M+H]+) is produced by streptomycetes and other bacteria. PTMs are a fast-growing antibiotic natural product family with diverse therapeutic properties, such as antibacterial, antifungal, antiprotozoal, and anticancer [70]. It has also been suggested that the fungicidal action of macrolide antibiotics is their affinity for binding to ergosterol within fungal membranes [71].

2.5.3. Coumarins

Coumarin and its derivatives represent one of the most active classes of compounds possessing biological activities [72], such as antibacterial, antifungal, antiviral, and anticancer [73]. Since the discovery of novobiocin (an aminocoumarin antibiotic) produced by Streptomyces niveus, coumarins have attracted more attention as potential antimicrobial agents. The GNPS library displayed a match to 6-methylcoumarin (m/z 161.060 [M+H]) produced by isolates USC-6932 and USC-6904. In a study conducted by Chen (2022), the antifungal activity of coumarins against phytopathogenic fungi was evaluated and found that 6-methylcoumarin presented with the strongest antifungal activity against Valsa mali [74]. Another coumarin was manually annotated as methoxsalen (m/z 217.045 [M+H]+) produced by isolates USC-592 and USC-6932 (Figure 6). Methoxsalen (xanthotoxin) is a photosensitising furocoumarin compound and has been used as the first treatment of mycosis fungoides [75].

2.5.4. Cyclic Peptides (Nocardamine)/Siderophores

Desferrioxamines are the principle siderophores produced by Streptomyces species [76]. Studies have shown that streptomycetes are able to use their siderophore production as a means to ‘starve’ fungi of iron [77] as an antagonistic mechanism. A cluster of siderophore peptides was also identified within the MN, including desferrioxamine E (synonym: nocardamine) (m/z 601.356 [M+H]+) which is a siderophore widely produced by Streptomyces species [76] and was found in isolates USC-595A and USC-592. Derivatives of this compound, also found in streptomycetes and identified as dehydroxynocardamine (m/z 585.631 [M+H]+), were found in isolate USC-592 (Figure 7).

2.6. Pathway Enrichment Analysis within the Streptomycetes Fermentation Extracts

Pathway enrichment analysis (PEA) and overrepresentation analysis (ORA) play vital roles in high-dimensional molecular data and are becoming popular methods for analysing metabolic data as these include specific fingerprints of cellular biochemistry [78,79]. These analyses were conducted to investigate the pathways that were amplified across all 15 streptomycete extracts and how they may support the metabolite identification within the molecular networks of this study. The PEA revealed multiple pathways of interest due to their role in antibiotic synthesis. These include streptomycin biosynthesis, polyketide sugar unit biosynthesis, monobactam synthesis, siderophore group nonribosomal peptides synthesis, terpenoid backbone synthesis, biosynthesis of secondary metabolites, streptomycin synthesis, and novobiocin synthesis. Similarly, the ORA demonstrated enriched metabolite sets of interest, including (i) purine metabolism; (ii) phenylalanine, tyrosine, and tryptophan synthesis; and (iii) neomycin, kanamycin, and gentamicin biosynthesis.
Purine metabolism plays a crucial role in supplying energy and essential precursors for antibiotic biosynthesis in Streptomyces spp. [80]. Furthermore, it was reported that phenylalanine deaminates to trans-cinnamic acid, which ultimately can be converted into secondary metabolites, such as lignins, flavonoids, and coumarins, all of which were identified within the molecular network in this study [58,81]. One study investigated an endophytic Streptomyces isolate and discovered antibiotics kanamycin and gentamicin within their metabolomic analysis [82,83]. The ORA supports the detected metabolites in the molecular network and validates key compounds such as flavonoids and courmarins.
Important pathways responsible for secondary metabolite production include polyketide synthases (PKS) type I, II, and III, as well as nonribosomal peptide synthase (NRPS), both of which were identified within the PEA of this study. PKS genes encode polyketide metabolites such as antifungal antibiotic amphotericin B [84]. Researchers have reported the biosynthesis behind macrocyclic polyketides (macrolide antibiotics) by investigating the encoded PKS pathway. They revealed that these products are synthesised from acetate, propionate, and other short-chain fatty acids within this pathway and, thus, form a hydroxylated macrocyclic lactone ring with three to seven conjugated double bonds and one or more sugars [85,86]. Many of the enriched pathways support the finding presented in the MN and the possibility of the biosynthetic potential of these termite gut-associated Streptomyces in producing novel antifungal antibiotics(Figure 8).

3. Materials and Methods

3.1. Cultures and Culture Media

The 37 actinomycete isolates screened in this study were previously isolated from the guts of termites, Coptotermes lacteus (Froggatt) species located in the Sunshine Coast Region of Queensland, Australia [36,37], and cryogenically preserved in the University of the Sunshine Coast Microbial Library. The actinomycetes were grown onto oatmeal agar [87], and the P. noxium strain was previously isolated from infected heritage fig trees within Brisbane, Queensland, and grown on potato dextrose agar (PDA) (OXOID, Australia).

3.2. 16S rDNA Oligonucleotide Sequencing of Actinomycete Isolates

Extraction and amplification of the 16S rDNA were carried out using a commercial QIAGEN HotStarTaq DNA PCR kit as per the manufacturer’s instructions and using the eubacterial universal primers 27F 5′ -AGAGTT TGA TCC TGG CTC AG-3′ and 1492R 5′-GGT TAC CTT GTT ACG ACT T-3′. Conventional PCR reactions were performed achieving a final volume of 50 µL; 2× PCR master mix 25 µL, 10× primer mix 5 µL, Q-solution 10 µL, and RNase-free water 10 µL. Amplification was performed using the Bio-Rad T100 Thermocycler, (McHugh Electronic, Australia) with thermocycling conditions beginning with the initial temperature of 95 °C for 15 min, followed by 35 cycles of 94 °C for 1 min, 68 °C for 1 min, and final temperature of 72 °C for 10 min. PCR products were electrophoresed on a 1.5% agarose gel followed by visual confirmation under an IV transilluminator. The PCR products were sent to Macrogen (Seoul, Republic of Korea) (http://dna.macrogen.com/eng/, accessed on 22 November 2021) for sequencing. The sequences were analysed using Geneious Prime 23023.1.2 and putative identifications were made by conducting a BLAST (Basic Local Alignment Search Tool) search using the NCBI (National Centre for Biotechnology Information) database. This database is also where the sequences generated from this study have been deposited. Reference and generated accession numbers can be found in the Supplementary Materials.

3.3. Evaluation of Antifungal Activity of the Actinomycete Isolates

The 37 actinomycete isolates were screened for antifungal activity against the fungal pathogen P. noxium using co-culture assays. The isolates were streaked at one end of the agar plate and incubated for 7 days to grow at 28 °C before a fungal plug was placed at the opposing end of the plate. A control plate was also established without the Streptomyces isolates. Once the control had reached the edge of the plate, comparisons were made using the following formula:
I n h i b i t i o n   Z o n e   % = C o l o n y   d i a m e t e r   o f   p a t h o g e n c o l o n y   d i a m e t e r   o f   p a t h o g e n + a n t a g o n i s t C o l o n y   d i a m e t e r   o f   p a t h o g e n × 100

3.4. Fermentation and Extraction of Metabolites Produced by Streptomyces Isolates

Fermentation of the Streptomyces isolates was conducted using solid-state fermentation. The isolates were inoculated onto oatmeal agar plates and incubated for 7 days at 28 °C. The plates were then inoculated with a fungal plug from the P. noxium and grown for three more days using the same conditions. These plates were then twice extracted using ethyl acetate (ChemSupply) (EtOAc) by cutting up the agar and flooding them with the solvent for 24 h. The solvent was filtered and evaporated under a vacuum to obtain the crude extract for further testing.

3.5. Bioassays of the Streptomycetes Fermentation Extracts Using Disk-Diffusion Method

The antifungal activity of the crude extracts was then assessed using the Kirby-Bauer disk-diffusion method [88]. Sterile paper disks were seeded with the crude extract (approx. 100 µL) and placed onto PDA plates (2 cm away from the edge) (left). A blank control disk was also added, containing only DMSO on the opposing side (right). A fungal plug from the fungal pathogen was placed onto the centre of the plate and was incubated at 25 °C for four days. Signs of inhibition of the fungal mycelium were then observed.

3.6. QTOF Chemical Profiling of the Metabolites within the Streptomyces Fermentation Extracts

Liquid chromatography with accurate mass spectroscopy (LC-MS) was performed on a SCIEX ExionLC system coupled to a SCIEX X500 QTOF. The column was a Synergi Fusion RP, 50 mm × 4.6 mm, 2.5 µm. Mobile phase A was 99.9% MilliQ water with 0.1% formic acid, and mobile phase B was 99.9% LC-grade methanol with 0.1% formic acid. The mobile phase program was 1.0 mL/min commencing at 98:2 MPA: MPB for 0.25 min, grading to 100% MPB at 6.25 min, isocratic until 8.25 min, grading back to 98:2 MPA:MPB at 8.5 min, and isocratic until 10.0 min. The mass spectrometer was operated in alternating positive and negative electrospray ionisation modes, providing accurate M+1 and M-1 molecular ions to four decimal places.

3.7. MS Data Analysis and Annotation

The data were initially converted from “.wiff” standard file format to “.mzXML” using MSconvert within the ProteoWizard 3.0 software toolkit. The data were then processed using MZmine 2.53 and exported as a .CSV file where it was analysed using MetaboAnalyst 5.0 (https://new.metaboanalyst.ca, accessed on 22 November 2021), which allowed for the generation of principal component analysis (PCA), pathway enrichment analysis (PEA), and overrepresentation analysis (ORA).
A molecular network was generated using the online workflow (https://ccms-ucsd.github.io/GNPSDocumentation/, accessed on 22 November 2021) on the GNPS website (http://gnps.ucsd.edu, accessed on 22 November 2021) (Wang et al., 2016) [89]. The precursor ion mass tolerance was set to 2.0 Da and a MS/MS fragment ion tolerance of 0.5 Da. A network was then created where edges were filtered to have a cosine score above 0.65 and more than 4 matched peaks. Further, edges between two nodes were kept in the network if and only if each of the nodes appeared in each other’s respective top 10 most similar nodes. Finally, the maximum size of a molecular family was set to 100, and the lowest-scoring edges were removed from molecular families until the molecular family size was below this threshold. The resulting network was visualized in Cytoscape. Annotations of the metabolites were first made by matching the spectra against GNPS’ spectral libraries. All matches between network spectra and library spectra were required to have a score above 0.7 and at least 4 matched peaks. Generated annotations were validated against the Metabolomics Standards Initiative (MSI) [90] and were in compliance with level 2 annotations corresponding to “putatively annotated compounds” [91].

4. Conclusions

In this study, the phylogeny and antifungal activity of termite gut-associated actinomycetes were investigated. The 16S rRNA gene analysis revealed a dominance of the members of the genus Streptomyces in the termite gut. Additionally, 15 of the Streptomyces isolates presented with strong antifungal activity against the phytopathogenic fungus P. noxium. Fermentation extracts of the selected isolates were analysed through the employment of MS-based metabolomics for the evaluation of their metabolome chemical composition. Known antifungal metabolites of the polyketide chemical class were identified, including isoflavonoids, macrolides, coumarins, and cyclic peptides. Pathway enrichment analyses supported the biosynthetic potential for antibiotic production by the Streptomyces isolates and the findings of the molecular networking. The results of this study provide insights into the chemical composition and biopotential of termite gut-associated Streptomyces isolates as unexplored sources for novel antifungal compounds for biocontrol applications.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics12091373/s1, Table S1: Termite gut-associated actinomycetes phylogeny; Table S2: Assigned GenBank accession numbers of the actinomycete isolates; Figure S1: Phylogenetic tree of the actinomycetes; Figure S2: Metabolite chemical class distribution; Figure S3: Distribution of polyketide metabolites across the fermentation extracts of streptomycetes.

Author Contributions

Conceptualization, C.A., T.D.T. and D.İ.K.; methodology, C.A.; formal analysis, C.A.; investigation, C.A. and T.D.T., resources, D.İ.K., T.D.T., K.F. and R.T.; data curation, C.A. and T.D.T.; writing—original draft preparation, C.A.; writing—review and editing, D.İ.K. and T.D.T.; supervision, T.D.T. and D.İ.K.; funding acquisition, D.İ.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Brisbane City Council, grant number R22_0098.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article or Supplementary Material.

Acknowledgments

Authors thank Louisa Parkinson and Elizabeth Dann, QAAFI, UQ for the provision of P. noxium.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Fones, H.N.; Bebber, D.P.; Chaloner, T.M.; Kay, W.T.; Steinberg, G.; Gurr, S.J. Threats to global food security from emerging fungal and oomycete crop pathogens. Nat. Food 2020, 1, 332–342. [Google Scholar] [CrossRef]
  2. Thambugala, K.M.; Daranagama, D.A.; Phillips, A.J.; Kannangara, S.D.; Promputtha, I. Fungi vs. fungi in biocontrol: An overview of fungal antagonists applied against fungal plant pathogens. Front. Cell. Infect. Microbiol. 2020, 10, 604923. [Google Scholar] [CrossRef]
  3. Stewart, J.; Kim, M.-S.; Ota, Y.; Sahashi, N.; Hanna, J.; Akiba, M.; Ata, J.; Atibalentja, N.; Brooks, F.; Chung, C.-L. Phylogenetic and population genetic analyses reveal three distinct lineages of the invasive brown root-rot pathogen, Phellinus noxius, and bioclimatic modeling predicts differences in associated climate niches. Eur. J. Plant Pathol. 2020, 156, 751–766. [Google Scholar] [CrossRef]
  4. Ann, P.; Lee, H.; Tsai, J. Survey of brown root disease of fruit and ornamental trees caused by Phellinus noxius in Taiwan. Plant Pathol. Bull. 1999, 8, 51–60. [Google Scholar]
  5. Chou, H.; Xiao, Y.-T.; Tsai, J.-N.; Li, T.-T.; Wu, H.-Y.; Liu, L.-y.D.; Tzeng, D.-S.; Chung, C.-L. In Vitro and in planta evaluation of Trichoderma asperellum TA as a biocontrol agent against Phellinus noxius, the cause of brown root rot disease of trees. Plant Dis. 2019, 103, 2733–2741. [Google Scholar] [CrossRef] [PubMed]
  6. Hsiao, W.-W.; Ting-Hsuan, H.; En-Jang, S. The pathogenicity of basidiospores of Phellinus noxius which causes brown root rot disease in Taiwan. Taiwania 2019, 64, 189–194. [Google Scholar]
  7. Akiba, M.; Ota, Y.; Tsai, I.J.; Hattori, T.; Sahashi, N.; Kikuchi, T. Genetic differentiation and spatial structure of Phellinus noxius, the causal agent of brown root rot of woody plants in Japan. PLoS ONE 2015, 10, e0141792. [Google Scholar] [CrossRef] [PubMed]
  8. Sahashi, N.; Akiba, M.; Ishihara, M.; Ota, Y.; Kanzaki, N. Brown root rot of trees caused by Phellinus noxius in the Ryukyu Islands, subtropical areas of Japan. For. Pathol. 2012, 42, 353–361. [Google Scholar] [CrossRef]
  9. Wang, Y.-F.; Meng, H.; Gu, V.W.; Gu, J.-D. Molecular diagnosis of the brown root rot disease agent Phellinus noxius on trees and in soil by rDNA ITS analysis. Appl. Environ. Biotechnol. 2016, 1, 81–91. [Google Scholar] [CrossRef]
  10. Zhang, H.; Ng, T.K.; Lee, K.C.; Leung, Z.W.; Yau, W.F.; Wong, W.S. Development and evaluation of loop-mediated isothermal amplification (LAMP) as a preliminary diagnostic tool for brown root rot disease caused by Phellinus noxius (Corner) GH cunningham in hong kong urban tree management. Sustainability 2022, 14, 9708. [Google Scholar] [CrossRef]
  11. Adra, C.; Panchalingam, H.; Kurtböke, D.İ. Termite–gut-associated actinomycetes as biological control agents against phytopathogen Pyrrhoderma noxium. Microbiol. Aust. 2022, 43, 190–193. [Google Scholar] [CrossRef]
  12. Dann, K.; Smith, L.; Shuey, L.; Begum, F. Phellinus noxius: A basidiomycete fungus impacting productivity of Australian avocados. In Proceedings of the 7th World Avocado Congress, Cairns, Australia, 5–9 September 2011. [Google Scholar]
  13. Panchalingam, H.; Ashfield-Crook, N.; Naik, V.; Frenken, R.; Foster, K.; Tomlin, R.; Shapcott, A.; Kurtböke, D.İ. Testing the biocontrol ability of a Trichoderma-Streptomycetes consortium against Pyrrhoderma noxium (Corner) LW Zhou and YC Dai in soil. J. Fungi 2022, 9, 67. [Google Scholar] [CrossRef] [PubMed]
  14. Schwarze, F.W.; Jauss, F.; Spencer, C.; Hallam, C.; Schubert, M. Evaluation of an antagonistic Trichoderma strain for reducing the rate of wood decomposition by the white rot fungus Phellinus noxius. Biol. Control 2012, 61, 160–168. [Google Scholar] [CrossRef]
  15. Caballero, J.R.I.; Ata, J.P.; Leddy, K.; Glenn, T.C.; Kieran, T.J.; Klopfenstein, N.B.; Kim, M.-S.; Stewart, J.E. Genome comparison and transcriptome analysis of the invasive brown root rot pathogen, Phellinus noxius, from different geographic regions reveals potential enzymes associated with degradation of different wood substrates. Fungal Biol. 2020, 124, 144–154. [Google Scholar] [CrossRef]
  16. Liu, T.Y.; Chen, C.H.; Yang, Y.L.; Tsai, I.J.; Ho, Y.N.; Chung, C.L. The brown root rot fungus Phellinus noxius affects microbial communities in different root-associated niches of Ficus trees. Environ. Microbiol. 2022, 24, 276–297. [Google Scholar] [CrossRef]
  17. Wu, Z.-C.; Chang, Y.-Y.; Lai, Q.-J.; Lin, H.-A.; Tzean, S.-S.; Liou, R.-F.; Tsai, I.J.; Chung, C.-L. Soil is not a reservoir for Phellinus noxius. Phytopathology 2020, 110, 362–369. [Google Scholar] [CrossRef]
  18. Tsang, K.S.W.; Cheung, M.K.; Lam, R.Y.C.; Kwan, H.S. A preliminary examination of the bacterial, archaeal, and fungal rhizosphere microbiome in healthy and Phellinus noxius-infected trees. MicrobiologyOpen 2020, 9, e1115. [Google Scholar] [CrossRef] [PubMed]
  19. Chung, C.-L.; Huang, S.-Y.; Huang, Y.-C.; Tzean, S.-S.; Ann, P.-J.; Tsai, J.-N.; Yang, C.-C.; Lee, H.-H.; Huang, T.-W.; Huang, H.-Y. The genetic structure of Phellinus noxius and dissemination pattern of brown root rot disease in Taiwan. PLoS ONE 2015, 10, e0139445. [Google Scholar] [CrossRef]
  20. Tchotet Tchoumi, J.M.; Coetzee, M.P.A.; Vivas, M.; Rajchenberg, M.; Roux, J. Wood-rotting basidiomycetes associated with declining native trees in timber-harvesting compartments of the Garden Route National Park of South Africa. Austral Ecol. 2017, 42, 947–963. [Google Scholar] [CrossRef]
  21. Poveda, J.; Abril-Urias, P.; Escobar, C. Biological control of plant-parasitic nematodes by filamentous fungi inducers of resistance: Trichoderma, mycorrhizal and endophytic fungi. Front. Microbiol. 2020, 11, 992. [Google Scholar] [CrossRef]
  22. Ghanem, G.A.; Gebily, D.A.; Ragab, M.M.; Ali, A.M.; Soliman, N.E.-D.K.; El-Moity, T.H.A. Efficacy of antifungal substances of three Streptomyces spp. against different plant pathogenic fungi. Egypt. J. Biol. Pest Control 2022, 32, 1–13. [Google Scholar] [CrossRef]
  23. Wang, D.; Li, Y.; Yuan, Y.; Chu, D.; Cao, J.; Sun, G.; Ai, Y.; Cui, Z.; Zhang, Y.; Wang, F. Identification of non-volatile and volatile organic compounds produced by Bacillus siamensis LZ88 and their antifungal activity against Alternaria alternata. Biol. Control 2022, 169, 104901. [Google Scholar] [CrossRef]
  24. Donald, L.; Pipite, A.; Subramani, R.; Owen, J.; Keyzers, R.A.; Taufa, T. Streptomyces: Still the biggest producer of new natural secondary metabolites, a current perspective. Microbiol. Res. 2022, 13, 418–465. [Google Scholar] [CrossRef]
  25. Kurtböke, D.İ. Bioactive actinomycetes: Reaching rarity through sound understanding of selective culture and molecular diversity. In Microbial Resources; Kurtböke, D.İ., Ed.; Academic Press: Cambridge, MA, USA; Elsevier: Amsterdam, The Netherlands, 2017; pp. 45–76. [Google Scholar]
  26. Ding, T.; Yang, L.-J.; Zhang, W.-D.; Shen, Y.-H. The secondary metabolites of rare actinomycetes: Chemistry and bioactivity. RSC Adv. 2019, 9, 21964–21988. [Google Scholar] [CrossRef]
  27. Chen, S.; Cheng, D.; Liu, Z.; Hassan, B.; Xu, Y. Community structure and antifungal activity of actinobacteria in a fungus-growing termite. Ecol. Entomol. 2023, 48, 251–262. [Google Scholar] [CrossRef]
  28. Kurtböke, D.İ.; French, J.R.; Hayes, R.A.; Quinn, R.J. Eco-taxonomic insights into actinomycete symbionts of termites for discovery of novel bioactive compounds. Biotechnol. Appl. Biodivers. 2015, 111–135. [Google Scholar]
  29. Ayu Krishanti, N.P.R.; Zulfiana, D.; Wikantyoso, B.; Zulfitri, A.; Yusuf, S. Antimicrobial production by an actinomycetes isolated from the termite nest. J. Trop. Life Sci. 2018, 8. [Google Scholar]
  30. Malavika, S.; Kranthi, S.; Shishira Rao, H.; Moily, S.S.; Martin Paul, A. Isolation of gut Actinobacteria from termites. In Methods in Actinobacteriology; Dharumadurai, D., Ed.; Springer Protocols Handbooks; Humana: New York, NY, USA, 2022; pp. 51–60. [Google Scholar] [CrossRef]
  31. Zeki, Ö.C.; Eylem, C.C.; Reçber, T.; Kır, S.; Nemutlu, E. Integration of GC–MS and LC–MS for untargeted metabolomics profiling. J. Pharm. Biomed. Anal. 2020, 190, 113509. [Google Scholar] [CrossRef]
  32. Abdelrahman, S.M.; Dosoky, N.S.; Hanora, A.M.; Lopanik, N.B. Metabolomic profiling and molecular networking of nudibranch-associated Streptomyces sp. SCSIO 001680. Molecules 2022, 27, 4542. [Google Scholar] [CrossRef]
  33. Nothias, L.-F.; Petras, D.; Schmid, R.; Dührkop, K.; Rainer, J.; Sarvepalli, A.; Protsyuk, I.; Ernst, M.; Tsugawa, H.; Fleischauer, M. Feature-based molecular networking in the GNPS analysis environment. Nat. Methods 2020, 17, 905–908. [Google Scholar] [CrossRef]
  34. Tinte, M.M.; Masike, K.; Steenkamp, P.A.; Huyser, J.; van der Hooft, J.J.; Tugizimana, F. Computational metabolomics tools reveal metabolic reconfigurations underlying the effects of biostimulant seaweed extracts on maize plants under drought stress conditions. Metabolites 2022, 12, 487. [Google Scholar] [CrossRef]
  35. Kurtböke, D.İ. Actino-Rush on the Sunshine Coast: Prospects for Bioprospecting. In Proceedings of the 10th International Congress on Culture Collections, Tsukuba, Japan, 10–15 October 2004; pp. 319–322. [Google Scholar]
  36. Kurtböke, D.İ.; French, J.R. Use of phage battery to investigate the actinofloral layers of termite gut microflora. J. Appl. Microbiol. 2007, 103, 722–734. [Google Scholar] [CrossRef]
  37. Kurtböke, D.İ.; French, J.R. Actinobacterial resources from termite guts for regional bioindustries. Microbiol. Aust. 2008, 29, 42–44. [Google Scholar] [CrossRef]
  38. Berasategui, A.; Shukla, S.; Salem, H.; Kaltenpoth, M. Potential applications of insect symbionts in biotechnology. Appl. Microbiol. Biotechnol. 2016, 100, 1567–1577. [Google Scholar] [CrossRef] [PubMed]
  39. Kaltenpoth, M. Actinobacteria as mutualists: General healthcare for insects? Trends Microbiol. 2009, 17, 529–535. [Google Scholar] [CrossRef] [PubMed]
  40. Sujada, N.; Sungthong, R.; Lumyong, S. Termite nests as an abundant source of cultivable actinobacteria for biotechnological purposes. Microbes Environ. 2014, 29, 211–219. [Google Scholar] [CrossRef] [PubMed]
  41. Watanabe, Y.; Shinzato, N.; Fukatsu, T. Isolation of actinomycetes from termites’ guts. Biosci. Biotechnol. Biochem. 2003, 67, 1797–1801. [Google Scholar] [CrossRef]
  42. Ayed, A.; Kalai-Grami, L.; Ben Slimene, I.; Chaouachi, M.; Mankai, H.; Karkouch, I.; Djebali, N.; Elkahoui, S.; Tabbene, O.; Limam, F. Antifungal activity of volatile organic compounds from Streptomyces sp. strain S97 against Botrytis cinerea. Biocontrol Sci. Technol. 2021, 31, 1330–1348. [Google Scholar] [CrossRef]
  43. Lyu, A.; Liu, H.; Che, H.; Yang, L.; Zhang, J.; Wu, M.; Chen, W.; Li, G. Reveromycins A and B from Streptomyces sp. 3–10: Antifungal activity against plant pathogenic fungi in vitro and in a strawberry food model system. Front. Microbiol. 2017, 8, 550. [Google Scholar] [CrossRef]
  44. Wan, M.; Li, G.; Zhang, J.; Jiang, D.; Huang, H.-C. Effect of volatile substances of Streptomyces platensis F-1 on control of plant fungal diseases. Biol. Control 2008, 46, 552–559. [Google Scholar] [CrossRef]
  45. Igarashi, M.; Kinoshita, N.; Ikeda, T.; Kameda, M.; Hamada, M.; Takeuchi, T. Resormycin, a novel herbicidal and antifungal antibiotic produced by a strain of Streptomyces platensis I. Taxonomy, production, isolation and biological properties. J. Antibiot. 1997, 50, 1020–1025. [Google Scholar] [CrossRef]
  46. Chen, Y.-L.; Zhao, J.; Liu, W.; Gao, J.-F.; Tao, L.-M.; Pan, H.-X.; Tang, G.-L. Identification of phoslactomycin biosynthetic gene clusters from Streptomyces platensis SAM-0654 and characterization of PnR1 and PnR2 as positive transcriptional regulators. Gene 2012, 509, 195–200. [Google Scholar] [CrossRef] [PubMed]
  47. Lai, B.; Dai, R.; Zeng, T.; Yao, J. Optimization of Fermentation Conditions and Properties of Secondary Metabolite of Streptomyces catenulae XG40. Chin. J. Biol. Control 2022, 38, 1242. [Google Scholar]
  48. Budi, M.B.S.; Giyanto, G.; Tondok, E.T. Isolation of actinomycetes from peatland to suppress the growth of Ganoderma boninense the causal agent of basal stem rot disease in oil palm. Biodiversitas J. Biol. Divers. 2022, 23. [Google Scholar] [CrossRef]
  49. Zhang, R.; Han, X.; Xia, Z.; Luo, X.; Wan, C.; Zhang, L. Streptomyces luozhongensis sp. nov., a novel actinomycete with antifungal activity and antibacterial activity. Antonie Van Leeuwenhoek 2017, 110, 195–203. [Google Scholar] [CrossRef]
  50. Marian, M.; Ohno, T.; Suzuki, H.; Kitamura, H.; Kuroda, K.; Shimizu, M. A novel strain of endophytic Streptomyces for the biocontrol of strawberry anthracnose caused by Glomerella cingulata. Microbiol. Res. 2020, 234, 126428. [Google Scholar] [CrossRef]
  51. Yang, P.; Li, M.; Zhao, J.; Zhu, M.; Shang, H.; Li, J.; Cui, X.; Huang, R.; Wen, M. Oligomycins A and C, major secondary metabolites isolated from the newly isolated strain Streptomyces diastaticus. Folia Microbiol. 2010, 55, 10–16. [Google Scholar] [CrossRef]
  52. De Simeis, D.; Serra, S. Actinomycetes: A never-ending source of bioactive compounds—An overview on antibiotics production. Antibiotics 2021, 10, 483. [Google Scholar] [CrossRef]
  53. Wang, Y.; Yang, D.; Bi, Y.; Yu, Z. Macrolides from Streptomyces sp. SN5452 and their antifungal activity against Pyricularia oryzae. Microorganisms 2022, 10, 1612. [Google Scholar] [CrossRef] [PubMed]
  54. Risdian, C.; Mozef, T.; Wink, J. Biosynthesis of polyketides in Streptomyces. Microorganisms 2019, 7, 124. [Google Scholar] [CrossRef] [PubMed]
  55. Li, S.; Yang, B.; Tan, G.-Y.; Ouyang, L.-M.; Qiu, S.; Wang, W.; Xiang, W.; Zhang, L. Polyketide pesticides from actinomycetes. Curr. Opin. Biotechnol. 2021, 69, 299–307. [Google Scholar] [CrossRef]
  56. Wang, J.-F.; Liu, S.-S.; Song, Z.-Q.; Xu, T.-C.; Liu, C.-S.; Hou, Y.-G.; Huang, R.; Wu, S.-H. Naturally occurring flavonoids and isoflavonoids and their microbial transformation: A review. Molecules 2020, 25, 5112. [Google Scholar] [CrossRef] [PubMed]
  57. Ebada, S.S.; Eze, P.; Okoye, F.B.; Esimone, C.O.; Proksch, P. The fungal endophyte Nigrospora oryzae produces quercetin monoglycosides previously known only from plants. ChemistrySelect 2016, 1, 2767–2771. [Google Scholar] [CrossRef]
  58. Moore, B.S.; Hertweck, C.; Hopke, J.N.; Izumikawa, M.; Kalaitzis, J.A.; Nilsen, G.; O’Hare, T.; Piel, J.; Shipley, P.R.; Xiang, L. Plant-like biosynthetic pathways in bacteria: From benzoic acid to chalcone. J. Nat. Prod. 2002, 65, 1956–1962. [Google Scholar] [CrossRef]
  59. Matseliukh, B.; Polishchuk, L.; Lutchenko, V.; Bambura, O.; Kopiyko, O. Synthesis of daidzein and genistein by streptomycetes and their effect on production of antibiotics. Mikrobiolohichnyi Zhurnal 2005, 67, 12–21. [Google Scholar]
  60. Kang, H.R.; Lee, D.; Benndorf, R.; Jung, W.H.; Beemelmanns, C.; Kang, K.S.; Kim, K.H. Termisoflavones A–C, isoflavonoid glycosides from termite-associated Streptomyces sp. RB1. J. Nat. Prod. 2016, 79, 3072–3078. [Google Scholar] [CrossRef]
  61. Savi, D.C.; Shaaban, K.A.; Gos, F.M.; Thorson, J.S.; Glienke, C.; Rohr, J. Secondary metabolites produced by Microbacterium sp. LGMB471 with antifungal activity against the phytopathogen Phyllosticta citricarpa. Folia Microbiol. 2019, 64, 453–460. [Google Scholar] [CrossRef] [PubMed]
  62. Pancu, D.F.; Scurtu, A.; Macasoi, I.G.; Marti, D.; Mioc, M.; Soica, C.; Coricovac, D.; Horhat, D.; Poenaru, M.; Dehelean, C. Antibiotics: Conventional therapy and natural compounds with antibacterial activity—A pharmaco-toxicological screening. Antibiotics 2021, 10, 401. [Google Scholar] [CrossRef]
  63. Bao, Y.; Li, H.; Dong, Y.; Duan, H.; Li, H.; Li, W. Genome-guided discovery of antifungal filipins from a deep-sea-derived Streptomyces antibioticus. J. Nat. Prod. 2022, 85, 365–374. [Google Scholar] [CrossRef]
  64. Jizba, J.; Sedmera, P.; Zima, J.; Beran, M.; Blumauerová, M.; Kandybin, N.; Samoukina, G. Macrotetrolide antibiotics produced by Streptomyces globisporus. Folia Microbiol. 1991, 36, 437–443. [Google Scholar] [CrossRef]
  65. Wang, J.; Tan, H.; Lu, Y.; Cao, L. Determination of ionophore antibiotics nactins produced by fecal Streptomyces from sheep. BioMetals 2014, 27, 403–407. [Google Scholar] [CrossRef]
  66. Shishlyannikova, T.A.; Kuzmin, A.V.; Fedorova, G.A.; Shishlyannikov, S.M.; Lipko, I.A.; Sukhanova, E.V.; Belkova, N.L. Ionofore antibiotic polynactin produced by Streptomyces sp. 156A isolated from Lake Baikal. Nat. Prod. Res. 2017, 31, 639–644. [Google Scholar] [CrossRef] [PubMed]
  67. Zhang, K.; Gu, L.; Zhang, Y.; Liu, Z.; Li, X. Dinactin from a new producer, Streptomyces badius gz-8, and its antifungal activity against the rubber anthracnose fungus Colletotrichum gloeosporioides. Microbiol. Res. 2020, 240, 126548. [Google Scholar] [CrossRef] [PubMed]
  68. Khebizi, N.; Boudjella, H.; Bijani, C.; Bouras, N.; Klenk, H.-P.; Pont, F.; Mathieu, F.; Sabaou, N. Oligomycins A and E, major bioactive secondary metabolites produced by Streptomyces sp. strain HG29 isolated from a Saharan soil. J. De Mycol. Medicale 2018, 28, 150–160. [Google Scholar] [CrossRef]
  69. Chakraborty, M.; Mahmud, N.U.; Muzahid, A.N.M.; Rabby, S.F.; Islam, T. Oligomycins inhibit Magnaporthe oryzae Triticum and suppress wheat blast disease. PLoS ONE 2020, 15, e0233665. [Google Scholar] [CrossRef]
  70. Yu, L.; Li, H.; Zhou, Z.; Liu, F.; Du, L. An antifungal polycyclic tetramate macrolactam, heat-stable antifungal factor (HSAF), is a novel oxidative stress modulator in Lysobacter enzymogenes. Appl. Environ. Microbiol. 2021, 87, e03105–e03120. [Google Scholar] [CrossRef]
  71. Gray, K.C.; Palacios, D.S.; Dailey, I.; Endo, M.M.; Uno, B.E.; Wilcock, B.C.; Burke, M.D. Amphotericin primarily kills yeast by simply binding ergosterol. Proc. Natl. Acad. Sci. USA 2012, 109, 2234–2239. [Google Scholar] [CrossRef]
  72. Al-Amiery, A.A.; Kadhum, A.A.H.; Mohamad, A.B. Antifungal activities of new coumarins. Molecules 2012, 17, 5713–5723. [Google Scholar] [CrossRef]
  73. Hussain, M.I.; Syed, Q.A.; Khattak, M.N.K.; Hafez, B.; Reigosa, M.J.; El-Keblawy, A. Natural product coumarins: Biological and pharmacological perspectives. Biologia 2019, 74, 863–888. [Google Scholar] [CrossRef]
  74. Chen, Y.-Z.; Wang, S.-R.; Li, T.; Zhang, G.-C.; Yang, J. Antifungal activity of 6-Methylcoumarin against Valsa mali and its possible mechanism of action. J. Fungi 2022, 9, 5. [Google Scholar] [CrossRef] [PubMed]
  75. Rodrigues, J.L.; Gomes, D.; Rodrigues, L.R. Challenges in the heterologous production of furanocoumarins in Escherichia coli. Molecules 2022, 27, 7230. [Google Scholar] [CrossRef]
  76. Yamanaka, K.; Oikawa, H.; Ogawa, H.-o.; Hosono, K.; Shinmachi, F.; Takano, H.; Sakuda, S.; Beppu, T.; Ueda, K. Desferrioxamine E produced by Streptomyces griseus stimulates growth and development of Streptomyces tanashiensis. Microbiology 2005, 151, 2899–2905. [Google Scholar] [CrossRef]
  77. Jarmusch, S.A.; Lagos-Susaeta, D.; Diab, E.; Salazar, O.; Asenjo, J.A.; Ebel, R.; Jaspars, M. Iron-meditated fungal starvation by lupine rhizosphere-associated and extremotolerant Streptomyces sp. S29 desferrioxamine production. Mol. Omics 2021, 17, 95–107. [Google Scholar] [CrossRef] [PubMed]
  78. Chen, Y.; Li, E.-M.; Xu, L.-Y. Guide to metabolomics analysis: A bioinformatics workflow. Metabolites 2022, 12, 357. [Google Scholar] [CrossRef]
  79. Wieder, C.; Frainay, C.; Poupin, N.; Rodríguez-Mier, P.; Vinson, F.; Cooke, J.; Lai, R.P.; Bundy, J.G.; Jourdan, F.; Ebbels, T. Pathway analysis in metabolomics: Recommendations for the use of over-representation analysis. PLoS Comput. Biol. 2021, 17, e1009105. [Google Scholar] [CrossRef]
  80. Sivapragasam, S.; Grove, A. The link between purine metabolism and production of antibiotics in Streptomyces. Antibiotics 2019, 8, 76. [Google Scholar] [CrossRef]
  81. Kumavath, R.N.; Barh, D.; Azevedo, V.; Kumar, A.P. Potential pharmacological applications of enzymes associated with bacterial metabolism of aromatic compounds. J. Microbiol. Antimicrob. 2017, 9, 1–13. [Google Scholar]
  82. Alam, K.; Mazumder, A.; Sikdar, S.; Zhao, Y.-M.; Hao, J.; Song, C.; Wang, Y.; Sarkar, R.; Islam, S.; Zhang, Y. Streptomyces: The biofactory of secondary metabolites. Front. Microbiol. 2022, 13, 968053. [Google Scholar] [CrossRef] [PubMed]
  83. Baba, M.S.; Mohamad Zin, N.; Ahmad, S.J.; Mazlan, N.W.; Baharum, S.N.; Ahmad, N.; Azmi, F. Antibiotic biosynthesis pathways from endophytic Streptomyces SUK 48 through metabolomics and genomics approaches. Antibiotics 2021, 10, 969. [Google Scholar] [CrossRef]
  84. Zhang, B.; Zhou, Y.-T.; Jiang, S.-X.; Zhang, Y.-H.; Huang, K.; Liu, Z.-Q.; Zheng, Y.-G. Amphotericin B biosynthesis in Streptomyces nodosus: Quantitative analysis of metabolism via LC–MS/MS based metabolomics for rational design. Microb. Cell Factories 2020, 19, 1–12. [Google Scholar] [CrossRef]
  85. Mulks, M.; Nair, M.; Putnam, A. In vitro antibacterial activity of faeriefungin, a new broad-spectrum polyene macrolide antibiotic. Antimicrob. Agents Chemother. 1990, 34, 1762–1765. [Google Scholar] [CrossRef] [PubMed]
  86. Yao, T.; Liu, Z.; Li, T.; Zhang, H.; Liu, J.; Li, H.; Che, Q.; Zhu, T.; Li, D.; Li, W. Characterization of the biosynthetic gene cluster of the polyene macrolide antibiotic reedsmycins from a marine-derived Streptomyces strain. Microb. Cell Factories 2018, 17, 1–12. [Google Scholar] [CrossRef] [PubMed]
  87. Williams, S.; Wellington, E. Actinomycetes. In Methods of Soil Analysis: Part 2, Chemical and Microbiological Properties, Agronomy Monograph; Page, A.L., Ed.; American Society of Agronomy Inc.; Soil Science of America Inc.: Madison, WI, USA, 1983; pp. 969–987. [Google Scholar]
  88. Bauer, A.W.; Perry, D.M.; Kirby, W.M. Single-disk antibiotic-sensitivity testing of staphylococci: An analysis of technique and results. AMA Arch. Intern. Med. 1959, 104, 208–216. [Google Scholar] [CrossRef]
  89. Wang, M.; Carver, J.J.; Phelan, V.V.; Sanchez, L.M.; Garg, N.; Peng, Y.; Nguyen, D.D.; Watrous, J.; Kapono, C.A.; Luzzatto-Knaan, T.; et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34, 828–837. [Google Scholar] [CrossRef]
  90. Fiehn, O.; Robertson, D.; Griffin, J.; van der Werf, M.; Nikolau, B.; Morrison, N.; Sumner, L.W.; Goodacre, R.; Hardy, N.W.; Taylor, C. The metabolomics standards initiative (MSI). Metabolomics 2007, 3, 175–178. [Google Scholar] [CrossRef]
  91. Goodacre, R. Water, water, every where, but rarely any drop to drink. Metabolomics 2014, 10, 5–7. [Google Scholar] [CrossRef]
Figure 1. (A) Co-culture assays of the selected 15 termite gut-associated Streptomyces isolates and the P. noxium pathogen. (B) Percent inhibition of P. noxium mycelia when grown in co-culture with Streptomyces isolates. (C) Disk-diffusion assays of the Streptomyces isolate extracts against P. noxium (the left disk contains the active extracts, and the right disk is the control and contains EtOAc).
Figure 1. (A) Co-culture assays of the selected 15 termite gut-associated Streptomyces isolates and the P. noxium pathogen. (B) Percent inhibition of P. noxium mycelia when grown in co-culture with Streptomyces isolates. (C) Disk-diffusion assays of the Streptomyces isolate extracts against P. noxium (the left disk contains the active extracts, and the right disk is the control and contains EtOAc).
Antibiotics 12 01373 g001
Figure 2. (A) Two-dimensional PCA score plot demonstrating the differential production of metabolites between the fifteen Streptomyces isolates across the positive and negative ionisation modes (PC1 × PC2) and (B) a score plot comparing the active and non-active fermentation extracts.
Figure 2. (A) Two-dimensional PCA score plot demonstrating the differential production of metabolites between the fifteen Streptomyces isolates across the positive and negative ionisation modes (PC1 × PC2) and (B) a score plot comparing the active and non-active fermentation extracts.
Antibiotics 12 01373 g002
Figure 3. Termite gut-associated streptomycetes molecular network coloured by 11 chemical class terms as indicated by the legend. Chemical class annotation was performed using MolNetEnhancer within the GNPS framework (A) class annotated MN in a positive ionisation mode and (B) class annotated MN in a negative ionisation mode.
Figure 3. Termite gut-associated streptomycetes molecular network coloured by 11 chemical class terms as indicated by the legend. Chemical class annotation was performed using MolNetEnhancer within the GNPS framework (A) class annotated MN in a positive ionisation mode and (B) class annotated MN in a negative ionisation mode.
Antibiotics 12 01373 g003
Figure 4. Isoflavonoid metabolite cluster identified in the termite gut-associated streptomycetes molecular network. Nodes represent an individual metabolite; each node displays its parent mass and is coloured based on its retention time.
Figure 4. Isoflavonoid metabolite cluster identified in the termite gut-associated streptomycetes molecular network. Nodes represent an individual metabolite; each node displays its parent mass and is coloured based on its retention time.
Antibiotics 12 01373 g004
Figure 5. Macrotetrolide cluster identified in the termite gut-associated streptomycetes molecular network. Nodes represent an individual metabolite; each node displays its parent mass and is coloured based on its retention time. (A) macrotetrolides (B) macrocyclic lactones (C) polycyclic tetramate macrolactums.
Figure 5. Macrotetrolide cluster identified in the termite gut-associated streptomycetes molecular network. Nodes represent an individual metabolite; each node displays its parent mass and is coloured based on its retention time. (A) macrotetrolides (B) macrocyclic lactones (C) polycyclic tetramate macrolactums.
Antibiotics 12 01373 g005
Figure 6. Coumarin cluster identified in the termite gut-associated streptomycetes molecular network. Nodes represent an individual metabolite; each node displays its parent mass and is coloured based on its retention time.
Figure 6. Coumarin cluster identified in the termite gut-associated streptomycetes molecular network. Nodes represent an individual metabolite; each node displays its parent mass and is coloured based on its retention time.
Antibiotics 12 01373 g006
Figure 7. Peptide cluster identified in the termite gut-associated streptomycetes molecular network. Nodes represent an individual metabolite; each node displays its parent mass and is coloured based on its retention time.
Figure 7. Peptide cluster identified in the termite gut-associated streptomycetes molecular network. Nodes represent an individual metabolite; each node displays its parent mass and is coloured based on its retention time.
Antibiotics 12 01373 g007
Figure 8. (A) Pathway enrichment and (B) overrepresentation analyses generated in Metaboanalyst 5.0 of all 15 of the Streptomyces isolates from the MS data. The size of the circle is indicative of the pathway impact score, while the colours are based on the p-value (the darker the colour, the higher the significance of the metabolites within the relevant pathway).
Figure 8. (A) Pathway enrichment and (B) overrepresentation analyses generated in Metaboanalyst 5.0 of all 15 of the Streptomyces isolates from the MS data. The size of the circle is indicative of the pathway impact score, while the colours are based on the p-value (the darker the colour, the higher the significance of the metabolites within the relevant pathway).
Antibiotics 12 01373 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Adra, C.; Tran, T.D.; Foster, K.; Tomlin, R.; Kurtböke, D.İ. Untargeted MS-Based Metabolomic Analysis of Termite Gut-Associated Streptomycetes with Antifungal Activity against Pyrrhoderma noxium. Antibiotics 2023, 12, 1373. https://doi.org/10.3390/antibiotics12091373

AMA Style

Adra C, Tran TD, Foster K, Tomlin R, Kurtböke Dİ. Untargeted MS-Based Metabolomic Analysis of Termite Gut-Associated Streptomycetes with Antifungal Activity against Pyrrhoderma noxium. Antibiotics. 2023; 12(9):1373. https://doi.org/10.3390/antibiotics12091373

Chicago/Turabian Style

Adra, Cherrihan, Trong D. Tran, Keith Foster, Russell Tomlin, and D. İpek Kurtböke. 2023. "Untargeted MS-Based Metabolomic Analysis of Termite Gut-Associated Streptomycetes with Antifungal Activity against Pyrrhoderma noxium" Antibiotics 12, no. 9: 1373. https://doi.org/10.3390/antibiotics12091373

APA Style

Adra, C., Tran, T. D., Foster, K., Tomlin, R., & Kurtböke, D. İ. (2023). Untargeted MS-Based Metabolomic Analysis of Termite Gut-Associated Streptomycetes with Antifungal Activity against Pyrrhoderma noxium. Antibiotics, 12(9), 1373. https://doi.org/10.3390/antibiotics12091373

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop